The mechanism of RNA interference for hepatocellular carcinoma treatment

doi:10.3760/cma.j.issn.1673-422X.2017.04.015

Abstract

Abstract: Primary liver cancer is one of the common malignant tumors. However, the efficacy of traditional treatments is not satisfactory. RNA interference is a new treatment method, which develops rapidly in recent years. It has been found that RNA interference can exert the antitumor effect through inhibiting the growth and proliferation of hepatocarcinoma cells, promoting apoptosis, inhibiting the invasion and metastasis of hepatocarcinoma cells, inhibiting angiogenesis and overcoming the resistance to chemotherapy.

Key words: Hepatocellular carcinoma, RNA interferece, Apoptosis, Angiogenesis

Hou Xiaoyun, Chu Yanjun.. The mechanism of RNA interference for hepatocellular carcinoma treatment[J]. Journal of International Oncology, 2017, 44(4): 297-299.

References

［1］ Jemal A, Bray F, Center MM, et al. Global cancer statistics［J］. CA Cancer J Clin, 2011, 61(2): 69-90. DOI: 10.3322/caac.20107. ［2］ Li L, Mu-oz-Culla M, Carmona U, et al. Ferritin-mediated siRNA delivery and gene silencing in human tumor and primary cells［J］. Biomaterials, 2016, 98: 143-151. DOI: 10.1016/j.biomaterials.2016.05.006. ［3］ PalancaWessels MC, Booth GC, Convertine AJ, et al. Antibody targeting facilitates effective intratumoral siRNA nanoparticle delivery to HER2overexpressing cancer cells［J］. Oncotarget, 2016, 7(8): 9561-9575. DOI: 10.18632/oncotarget.7076. ［4］ Vander Heiden MG, Cantley LC, Thompson CB. Understanding the warburg effect: the metabolic requirements of cell proliferation［J］. Science, 2009, 324(5930): 1029-1033. DOI: 10.1126/science.1160809. ［5］ Noguchi C, Kamitori K, Hossain A, et al. D-allose inhibits cancer cell growth by reducing GLUT1 expression［J］. Tohoku J Exp Med, 2016, 238(2): 131-141. DOI: 10.1620/tjem.238.131. ［6］ Huang Q, Li J, Xing J, et al. CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53dependent signaling pathway［J］. J Hepatol, 2014, 61(4): 859-866. DOI: 10.1016/j.jhep.2014.04.035. ［7］ Amann T, Maegdefrau U, Hartmann A, et al. GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis［J］. Am J Pathol, 2009, 174(4): 1544-1552. DOI: 10.2353/ajpath.2009.080596. ［8］ Cho-Rok J, Yoo J, Jang YJ, et al. Adenovirus-mediated transfer of siRNA against PTTG1 inhibits liver cancer cell growth in vitro and in vivo［J］. Hepatology, 2006, 43(5): 1042-1052. ［9］ Doan CC, Doan NT, Nguyen QH, et al. Downregulation of Kinesin spindle protein inhibits proliferation, induces apoptosis and increases chemosensitivity in hepatocellular carcinoma cells［J］. Iran Biomed J, 2015, 19(1): 1-16. ［10］ Liu W, Zhu F, Jiang Y, et al. siRNA targeting survivin inhibits the growth and enhances the chemosensitivity of hepatocellular carcinoma cells［J］. Oncol Rep, 2013, 29(3): 1183-1188. DOI: 10.3892/or.2012.2196. ［11］ Vogl TJ, Oppermann E, Qian J, et al. Transarterial chemoembolization of hepatocellular carcinoma in a rat model: the effect of additional injection of survivin siRNA to the treatment protocol［J］. BMC Cancer, 2016, 16: 325. DOI: 10.1186/s12885-016-2357-3. ［12］ Zhao A, Zeng Q, Xie X, et al. MicroRNA-125b induces cancer cell apoptosis through suppression of Bcl-2 expression［J］. J Genet Genomics, 2012, 39(1): 29-35. DOI: 10.1016/j.jgg.2011.12.003. ［13］ Fu BH, Wu ZZ, Qin J. Effects of integrin α6β1 on migration of hepatocellular carcinoma cells［J］. Mol Biol Rep, 2011, 38(5): 3271-3276. DOI: 10.1007/s11033-0100308-7. ［14］ Lv G, Lv T, Qiao S, et al. RNA interference targeting human integrin α6 suppresses the metastasis potential of hepatocellular carcinoma cells［J］. Eur J Med Res, 2013, 18: 52. DOI: 10.1186/2047-783X-18-52. ［15］ Wu JM, Xu Y, Skill NJ, et al. Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma［J］. Mol Cancer, 2010, 9: 71. DOI: 10.1186/1476-4598-9-71. ［16］ BenBaruch A. Organ selectivity in metastasis: regulation by chemokines and their receptors［J］. Clin Exp Metastasis, 2008, 25(4): 345-356. DOI: 10.1007/s10585-007-9097-3. ［17］ Xue TC, Chen RX, Han D, et al. Down-regulation of CXCR7 inhibits the growth and lung metastasis of human hepatocellular carcinoma cells with highly metastatic potential［J］. Exp Ther Med, 2012, 3(1): 117-123. ［18］ Lu Y, Zhu M, Li W, et al. Alpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells［J］. J Cell Mol Med, 2016, 20(3): 549-558. DOI: 10.1111/jcmm.12745. ［19］ Weis SM, Cheresh DA. Tumor angiogenesis: molecular pathways and therapeutic targets［J］. Nat Med, 2011, 17(11): 1359-1370. DOI: 10.1038/nm.2537. ［20］ Chen S, Feng J, Ma L, et al. RNA interference technology for anti-VEGF treatment［J］. Expert Opin Drug Deliv, 2014, 11(9): 1471-1480. DOI: 10.1517/17425247.2014.926886. ［21］ Zou Y, Guo CG, Zhang MM. Inhibition of human hepatocellular carcinoma tumor angiogenesis by siRNA silencing of VEGF via hepatic artery perfusion［J］. Eur Rev Med Pharmacol Sci, 2015, 19(24): 4751-4761. ［22］ Hague S, Zhang L, Oehler MK, et al. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density［J］. Clin Cancer Res, 2000, 6(7): 2808-2814. ［23］ Li F, Yang R, Zhang X, et al. Silencing of hypoxia-inducible adrenomedullin using RNA interference attenuates hepatocellular carcinoma cell growth in vivo［J］. Mol Med Rep, 2014, 10(3): 1295-1302. DOI: 10.3892/mmr.2014.2320. ［24］ Meng W, Li X, Bai Z, et al. Silencing alphafetoprotein inhibits VEGF and MMP-2/9 production in human hepatocellular carcinoma cell［J］. PLoS One, 2014, 9(2): e90660. DOI: 10.1371/journal.pone.0090660. ［25］ Yang T, Zheng ZM, Li XN, et al. MiR-223modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells［J］. Exp Biol Med (Maywood), 2013, 238(9): 1024-1032. DOI: 10.1177/1535370213497321. ［26］ Su Z, Liu G, Fang T, et al. Silencing MRP1-4 genes by RNA interference enhances sensitivity of human hepatoma cells to chemotherapy［J］. Am J Transl Res, 2016, 8(6): 2790-2802. ［27］ Tang B, Hu Z, Li Y, et al. Downregulation of δ opioidreceptor by RNA interference enhances the sensitivity of BEL/FU drug-resistant human hepatocellular carcinoma cells to 5-FU［J］. Mol Med Rep, 2016, 13(1): 59-66. DOI: 10.3892/mmr.2015.4511.

[1]	Ren Lu, Xie Xiaoli, Zhang Kun, Wang Lijuan. Effects and mechanisms of dihydroartemisinin combined with carfilzomib on the activity， proliferation， and apoptosis of multiple myeloma cells [J]. Journal of International Oncology, 2024, 51(3): 129-136.
[2]	Zhang Keping, Zhao Yongsheng, Yang Juan, Fu Maoyong. Chlorogenic acid induces mitochondrial dysfunction in lung cancer A549 cells by inhibiting the PI3K-Akt pathway [J]. Journal of International Oncology, 2024, 51(1): 21-28.
[3]	Liu Xiaodi, Su Jianfei, Zhang Jingxian, Wei Xueqin, Jia Yingjie. Research progress of myeloid-derived suppressor cells in tumor angiogenesis [J]. Journal of International Oncology, 2024, 51(1): 50-54.
[4]	Xiang Yuling, Tan Jiajie, Xiong Yuanguo, Zhao Lirong, Li Chen, Zhang Hong. Effects of Anhydroicaritin on the proliferation， migration and apoptosis of hepatocellular carcinoma cells [J]. Journal of International Oncology, 2023, 50(9): 513-519.
[5]	Feng Dongxu, Wu Wei, Gao Pingfa, Wang Jun, Shi Lijuan, Chen Dawei, Li Wenbing, Zhang Meifeng. Effects of miR-451 on glycolysis and apoptosis of breast cancer cells by regulating Rho/ROCK1 pathway [J]. Journal of International Oncology, 2023, 50(8): 449-456.
[6]	Pan Shulan, Liu Chang, He Ping. Effect of fritinib on angiogenesis, tumor growth and IRE1-ASK1-JNK pathway in triple negative breast cancer [J]. Journal of International Oncology, 2023, 50(8): 457-462.
[7]	Zhang Yuan, Bai Zhiyu, Li Qi, Feng Qinmei. Current status of research on exosomes in malignancies [J]. Journal of International Oncology, 2023, 50(8): 484-488.
[8]	Wu Jiali, Zhang Jiahui, Zhang Ping, Xiao Xinyue, Li Rui, Zhang Hongyu. Mechanism of Bcl-2 BH4 selective inhibitor BDA-366 on NK/T cell lymphoma cells [J]. Journal of International Oncology, 2023, 50(7): 413-418.
[9]	Yang Ya, Wang Huili, Liu Yan, Guo Jinfeng, Wang Chunxia, Lyu Min, Shan Changping. Effects of GCSH gene on proliferation and apoptosis of gastric cancer SNU-1 cells [J]. Journal of International Oncology, 2023, 50(5): 257-262.
[10]	Zhu Yi, Chen Jian. Mechanism of hydrogen sulfide in tumorigenesis and development and its donor-mediated anti-tumor effects [J]. Journal of International Oncology, 2023, 50(12): 729-733.
[11]	Lian Haiwei, Yang Shuorui, Liu Renzhong. Mechanism study on regulation of glioblastoma cell proliferation and apoptosis by sciadopitysin combined with CX-4945 through Notch1 pathway [J]. Journal of International Oncology, 2022, 49(6): 321-326.
[12]	Yang Ya, Ning Xiaofei, Li Bingliang, Yao Hui, Shan Changping, Lyu Min. Study on the mechanism of procyanidin mediated anti gastric cancer SNU-1 cell line by inducing the production of reactive oxygen species [J]. Journal of International Oncology, 2022, 49(5): 257-262.
[13]	Jiang Mengting, Wang Jiachun, Zong Jing. Effects of NFAT5 inhibition on proliferation, invasion, migration and apoptosis of lung adenocarcinoma cells [J]. Journal of International Oncology, 2021, 48(6): 321-327.
[14]	Wang Xianwei, Shi Meiyan, Wang Fengqin, Qi Fu, Wang Chaozhe, Zhou Fei. Roles of TSA upregulation miR-4298 targeting inhibition of PADI4 expression in inducing U251 cells apoptosis [J]. Journal of International Oncology, 2021, 48(4): 193-199.
[15]	Ma Xiuzhen, Lu Yan, Zhao Bingbing, Qiu Hongcong, Xu Xun, Wei Min. Effects of total flavonoids from Baeckea frutescens on the migration, invasion and apoptosis of cervical cancer SiHa cells [J]. Journal of International Oncology, 2021, 48(4): 206-211.